Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional Results available

Codex: Study of Inodiftagene Vixteplasmid (BC-819) in Unresponsive NMIBC

ClinicalTrials.gov ID: NCT03719300

Public ClinicalTrials.gov record NCT03719300. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 26, 2026, 2:06 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2 Study of BC-819 in Patients With Non-Muscle Invasive Bladder Cancer Whose Disease is Unresponsive to Bacillus Calmette-Guerin

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study, BC-819-18-204, is a Phase 2, open-label, monotherapy, single-arm, multicenter clinical trial of BC-819 (inodiftagene vixteplasmid) in patients with NMIBC adequately treated with Bacillus Calmette-Guerin (BCG) whose disease is BCG unresponsive according to the US Food and Drug Administration (FDA) guidance.

Study identification

NCT ID
NCT03719300
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Enrollment
32 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 20, 2019 (Actual)
Primary completion
Nov 18, 2019 (Actual)
Completion
Dec 18, 2019 (Actual)
Last update posted
Aug 19, 2020

2019

United States locations

U.S. sites
48
U.S. states
26
U.S. cities
43
Facility City State ZIP Site status
Alaska Urological Institute Anchorage Alaska 99503 —
Banner MD Anderson Cancer Center Gilbert Arizona 85234 —
Mayo Clinic Arizona Phoenix Arizona 85054 —
Urological Associates of Southern Arizona Tucson Arizona 85715 —
Arkansas Urology Little Rock Arkansas 72211 —
American Institute of Research Los Angeles California 90017 —
UC Davis Medical Center Sacramento California 95817 —
The Urology Center of Colorado Denver Colorado 80211 —
Mayo Clinic Florida Jacksonville Florida 32224 —
University of Florida Health Jacksonville, Shands Hospital Jacksonville Florida 33209 —
Emory University Atlanta Georgia 30322 —
North Idaho Urology Coeur d'Alene Idaho 83814 —
Idaho Urologic Institute, PA Meridian Idaho 83642 —
University of Illinois Hospital and Health Systems (Outpatient Care Center) Chicago Illinois 60612 —
The University of Kansas Cancer Center Westwood Kansas 66205 —
Wichita Urology Group Wichita Kansas 67226 —
Tulane University School of Medicine New Orleans Louisiana 70114 —
Ochsner Clinical Foundation New Orleans Louisiana 70121 —
Johns Hopkins Medical Institution Baltimore Maryland 21287 —
Spectrum Health Medical Group Grand Rapids Michigan 49546 —
Michigan Institute of Urology, PC Troy Michigan 48084 —
Mayo Clinic Rochester Minnesota 55905 —
Saint Louis University St Louis Missouri 63110 —
Washington University St Louis Missouri 63110 —
New Jersey Urology, LLC Belleville New Jersey 08043 —
MD Anderson Cancer Center at Cooper Voorhees Township New Jersey 08103 —
Albany Medical College Albany New York 12208 —
Weill Cornell Medical College - NY Presbyterian Hospital New York New York 10065 —
SUNY Upstate Medical University Syracuse New York 13210 —
Montefiore Medical Center The Bronx New York 10461 —
UNC Chapel Hill Hospital, Urology Clinic Chapel Hill North Carolina 27514 —
Duke University Durham North Carolina 27710 —
Alliance Urology Specialists, PA Greensboro North Carolina 27403 —
Carolina Urology Partners, PLLC Huntersville North Carolina 28078 —
University of Toledo, Dept. of Urology and Kidney Transplant Toledo Ohio 43614 —
University of Oklahoma Health Sciences Center Oklahoma City Oklahoma 73104 —
MidLantic Urology Bala-Cynwyd Pennsylvania 19004 —
The Hospital of the University of Pennsylvania Philadelphia Pennsylvania 19104 —
Medical University South Carolina Charleston South Carolina 29425 —
Regional Urology Greenville South Carolina 29605 —
Urology Associates, P.C. Nashville Tennessee 37209 —
University of Texas Southwestern Medical Center Dallas Texas 75390 —
Baylor College of Medicine Medical Center Houston Texas 77030 —
The Methodist Hospital d/b/a Houston Methodist Hospital Houston Texas 77030 —
The University of Texas MD Anderson Cancer Center Houston Texas 77030 —
Virginia Urology Richmond Virginia 23235 —
Urology of Virginia Virginia Beach Virginia 23462 —
West Virginia University Cancer Institute Morgantown West Virginia 26506 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03719300, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 19, 2020 · Synced Oct 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03719300 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →